BlackRock Group’s ResMed RMD Stock Holding History

BlackRock Group’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$58.1M	Buy	935,885 +18,205	+2%	+$1.12M	0.03%	564
2016 Q3	$59.5M	Buy	917,680 +315,398	+52%	+$21M	0.03%	549
2016 Q2	$38.1M	Buy	602,282 +81,998	+16%	+$4.83M	0.02%	639
2016 Q1	$30.1M	Buy	520,284 +19,230	+4%	+$1.09M	0.02%	701
2015 Q4	$26.9M	Buy	501,054 +9,353	+2%	+$527K	0.01%	722
2015 Q3	$25.1M	Buy	491,701 +12,633	+3%	+$680K	0.01%	725
2015 Q2	$27M	Buy	479,068 +131	+0%	+$8.27K	0.01%	744
2015 Q1	$34.4M	Buy	478,937 +2,167	+0.5%	+$141K	0.02%	688
2014 Q4	$26.7M	Buy	476,770 +41,531	+10%	+$2.17M	0.01%	736
2014 Q3	$21.4M	Buy	435,239 +6,708	+2%	+$342K	0.01%	767
2014 Q2	$21.7M	Sell	428,531 -5,002	-1%	-$248K	0.01%	774
2014 Q1	$19.4M	Sell	433,533 -20,936	-5%	-$940K	0.01%	779
2013 Q4	$21.4M	Sell	454,469 -23,508	-5%	-$1.19M	0.01%	751
2013 Q3	$25.2M	Buy	477,977 +22,994	+5%	+$1.12M	0.02%	712
2013 Q2	$20.5M	Buy	+454,983	New	+$21.6M	0.02%	710

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Norges Bank Oslo, Norway $935B AUM

BlackRock Group's RMD Position: Q4 2016 in Review

BlackRock Group increased its ResMed (RMD) stake by 2% in Q4 2016, buying an estimated $1.12M and bringing the position to 935,885 shares worth $58.1M. The position accounts for 0.03% of the portfolio, ranked #564.

BlackRock Group first reported a position in RMD in Q2 2013 and has held it in 15 quarters since. The position peaked at $59.5M in Q3 2016. 361 funds tracked by Wall St. Rank hold RMD as of Q4 2016.

BlackRock Group held 935,885 shares of ResMed worth $58.1M as of Q4 2016.
BlackRock Group bought 18,205 ResMed shares in Q4 2016, an estimated $1.12M.
ResMed made up 0.03% of BlackRock Group's portfolio in Q4 2016, its #564 holding.
BlackRock Group first reported a position in ResMed in Q2 2013 and has held it in 15 quarters since.
BlackRock Group's ResMed position peaked at $59.5M in Q3 2016.
361 funds tracked by Wall St. Rank held ResMed as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.